- Prostate Cancer Mortality and Use of 5-Alpha Reductase Inhibitors
-
Foldes CA, Wang R, Canfield S
- KMID: 2471820
- World J Mens Health.
- 2020 Apr;38(2):139-140.
- doi: 10.5534/wjmh.190129
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Course of the Benign Prostate Hyplasia Patients during the Intermittent Use of 5-Alpha Reductase Inhibitors
-
Choi K, Kim B, Cho IC, Min SK
- KMID: 2467924
- Urogenit Tract Infect.
- 2019 Dec;14(3):93-98.
- doi: 10.14777/uti.2019.14.3.93
PURPOSE: 5-Alpha reductase inhibitors (5ARI), inhibit the conversion of testosterone to dihydrotestosterone, which is essential in prostate hyperplasia, and decreases the prostate volume directly. On the other hand, 5ARI have... -
- CITED
-
- Close
- SHARE
-
- Close
- alpha-Blocker Monotherapy and alpha-Blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years' Long-Term Results
-
Shin TJ, Kim CI, Park CH, Kim BH, Kwon YK
- KMID: 2315386
- Korean J Urol.
- 2012 Apr;53(4):248-252.
PURPOSE: We compared the effects of alpha-adrenergic receptor blocker (alpha-blocker) monotherapy with those of combination therapy with alpha-blocker and 5-alpha-reductase inhibitor (5-ARI) on benign prostatic hyperplasia (BPH) progression for over... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of 5-alpha Reductase Inhibitor on Storage Symptoms in Patients with Benign Prostatic Hyperplasia
-
Cho KJ, Kang SH, Kim HS, Koh JS, Kim JC
- KMID: 2232810
- Int Neurourol J.
- 2011 Sep;15(3):152-157.
PURPOSE: Many patients with benign prostatic hyperplasia (BPH) have storage symptoms. The aim of this study was to evaluate the effects of treatment with a 5-alpha reductase inhibitor (5ARI) on... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of 5-alpha Reductase Inhibitors on the Efficacy of Photoselective Vaporization of the Prostate with 120 W GreenLight HPS Laser
-
Park HJ, Kim HW, Kim TN, Park NC
- KMID: 2226470
- Korean J Androl.
- 2011 Aug;29(2):161-167.
- doi: 10.5534/kja.2011.29.2.161
PURPOSE: To evaluate the effect of preoperative 5-alpha reductase inhibitor (ARI) administration on the operative results of photoselective vaporization of prostate with 120W GreenLight HPS laser. MATERIALS AND METHODS: Data were... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
-
Choi H, Chang YS, Park BH, Ko DH, Moon YJ, Kim JB
- KMID: 2298808
- Korean J Androl.
- 2012 Apr;30(1):45-51.
- doi: 10.5534/kja.2012.30.1.45
PURPOSE: To compare the clinical therapeutic efficacy of finasteride and dutasteride as 5-alpha reductase inhibitor (5-ARI) in the medical treatment of benign prostate hyperplasia. MATERIALS AND METHODS: From July 2007 to... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Effects of Discontinuing 5-Alpha Reductase Inhibitor in Patients With Benign Prostatic Hyperplasia
-
Kim W, Jung JH, Kang TW, Song JM, Chung HC
- KMID: 1988453
- Korean J Urol.
- 2014 Jan;55(1):52-56.
- doi: 10.4111/kju.2014.55.1.52
PURPOSE: To assess changes in lower urinary tract symptoms (LUTS), prostate volume, and serum prostate-specific antigen (PSA) after discontinuation of 5-alpha reductase inhibitor (5ARI) combination therapy in patients with benign... -
- CITED
-
- Close
- SHARE
-
- Close
- The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride
-
Choi YH, Cho SY, Cho IR
- KMID: 2314614
- Korean J Urol.
- 2010 Oct;51(10):704-708.
PURPOSE: To compare and analyze the therapeutic effects and changes in the prostate-specific antigen (PSA) level with treatment with finasteride or dutasteride for benign prostatic hyperplasia (BPH) for 1 year. MATERIALS... -
- CITED
-
- Close
- SHARE
-
- Close
- Voiding Dysfunctions in Primary Care Practices
-
Lee KS
- KMID: 2064940
- J Korean Med Assoc.
- 2005 Aug;48(8):744-754.
- doi: 10.5124/jkma.2005.48.8.744
The availability of new urologic medications has made it possible to manage a variety of urologic disorders successfully in a primary care setting. As a result, primary care physicians(PCPs) need... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of Loxoprofen Sodium on Nocturia in Patients with Benign Prostatic Hyperplasia
-
Chang HS, Kim BK, Sohn JC, Park CH, Kim CI
- KMID: 2139760
- Korean J Urol.
- 2007 Feb;48(2):195-198.
- doi: 10.4111/kju.2007.48.2.195
PURPOSE: The effectiveness of Loxoprofen sodium, a non-steroidal anti-inflammatory drug (NSAID), on the nocturia in patients with benign prostatic hyperplasia (BPH), not responding to anticholinergics or hypnotics, as well as... -
- CITED
-
- Close
- SHARE
-
- Close
- Benign Prostatic Hyperplasia
-
Kim CS
- KMID: 2184873
- J Korean Med Assoc.
- 2007 Jul;50(7):626-636.
- doi: 10.5124/jkma.2007.50.7.626
Benign prostatic hyperplasia (BPH), a pathological terminology that means benign proliferation of prostatic tissue, is commonly used as a clinical terminology indicating low urinary tract symptoms (LUTS) resulting from prostate... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effects of 5-alpha Reductase Inhibitor on Contr action of Erectile Tissue and Secretion of Seminal Fluid in Male Rabbits: Preliminary Study
-
Lee SY, Ha MS, Nguyen HB, Lee JH, Lee JH, Myung SC, Kim SC
- KMID: 2298622
- Korean J Androl.
- 2011 Apr;29(1):21-26.
- doi: 10.5534/kja.2011.29.1.21
PURPOSE: Adverse sexual experiences such as erectile dysfunction (ED), loss of libido, and ejaculation disorders have been consistent side effects of 5-alpha reductase inhibitors (5ARI). The aim of this study... -
- CITED
-
- Close
- SHARE
-
- Close
- Significance of intraprostatic architecture and regrowth velocity for considering discontinuation of dutasteride after combination therapy with an alpha blocker: A prospective, pilot study
-
Shindo T, Hashimoto , Shimizu T, Itoh N, Masumori N
- KMID: 2155306
- Korean J Urol.
- 2015 Apr;56(4):305-309.
- doi: 10.4111/kju.2015.56.4.305
PURPOSE: We conducted a prospective single-center study to evaluate the possibility of discontinuation of dutasteride after combination therapy with an alpha blocker for benign prostatic hyperplasia (BPH). MATERIALS AND METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia
-
Chung JS, Seo WI, Oh CK, Kim SC, Park MC, Park SH, Yu J, Lee CH, Kim W, Park TY, Min KS, Chung JI
- KMID: 2466794
- Investig Clin Urol.
- 2020 Jan;61(1):67-74.
- doi: 10.4111/icu.2020.61.1.67
PURPOSE: Preoperative use of 5α-reductase inhibitors (5ARIs) may cause fibrosis of the prostate tissue and reduce the efficiency of thulium laser surgery for treating benign prostate hyperplasia (BPH). Thus, we... -
- CITED
-
- Close
- SHARE
-
- Close
- Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate Biopsy
-
Heo JE, Koo KC, Hong SJ, Park SU, Chung BH, Lee KS
- KMID: 2418784
- Yonsei Med J.
- 2018 Mar;59(2):219-225.
- doi: 10.3349/ymj.2018.59.2.219
PURPOSE: To evaluate parameters for determining repeat prostate biopsy in patients with 5α-reductase inhibitor (5ARI) treatment after initial negative biopsy. MATERIALS AND METHODS: From January 2007 to December 2015, patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
-
Sung HH, Yu J, Kang SJ, Chae MR, So I, Park JK, Lee SW
- KMID: 2443240
- World J Mens Health.
- 2019 May;37(2):240-248.
- doi: 10.5534/wjmh.180082
PURPOSE: The current study is aimed to assess whether a longer duration of 5α-reductase inhibitor (5α-RI) exposure was associated with higher rate of permanent erectile dysfunction (ED) in a rat... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and Efficacy of the Coadministration of Sildenafil and Finasteride
-
Lee SW, Lee SH, Kim KS, Lee S, Chung JH
- KMID: 2438597
- Korean J Urol Oncol.
- 2018 Aug;16(2):69-74.
- doi: 10.22465/kjuo.2018.16.2.69
PURPOSE: The 5-alpha reductase inhibitors (5ARI) are one of the most commonly used medications for the treatment of benign prostatic hyperplasia (BPH). Phosphodiesterase type-5 inhibitors are also used to treat... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative analysis of benign prostatic hyperplasia management by urologists and nonurologists: A Korean nationwide health insurance database study
-
Park J, Lee YJ, Lee JW, Yoo TK, Chung JI, Yun SJ, Hong JH, Seo SI, Cho SY, Son H
- KMID: 2133292
- Korean J Urol.
- 2015 Mar;56(3):233-239.
- doi: 10.4111/kju.2015.56.3.233
PURPOSE: To compare the current management of benign prostatic hyperplasia (BPH) by urologists and nonurologists by use of Korean nationwide health insurance data. MATERIALS AND METHODS: We obtained patient data from... -
- CITED
-
- Close
- SHARE
-
- Close
- Cut-off Point of Large Prostate Volume for the Patients with Benign Prostatic Hyperplasia
-
Cho JS, Kim CI, Seong DH, Kim HS, Kim YS, Kim SJ, Cho IR, Cheon SH, Lee DH, Yang WJ, Choi YD, Hong SJ, Ju YS, Song YS, Kim SI, Chung BH
- KMID: 2293800
- Korean J Urol.
- 2005 Dec;46(12):1246-1250.
PURPOSE: Prostate volume (PV) is a key predictor of both the progression and response to medical therapy for the patients suffering with benign prostatic hyperplasia (BPH). 5 alpha reductase inhibitors... -
- CITED
-
- Close
- SHARE
-
- Close
